Freezers, shipping containers, and tracking systems aid distribution of COVID-19 vaccines.
A series of advancements has changed the way bioprocesses are developed and optimized.
A consistent approach in assessing risk is an important aspect of successful quality management.
Webinar Date/Time: Thu, May 15, 2025 11:00 AM EDT
What will manufacturers have to do to ensure the continued uptake of biosimilars?
This report describes the first known attempt at quantifying the success of such processes in inducing nucleation on a 56–m2 freeze dryer operating at a load of 195,960 vials.
This report describes the first known attempt at quantifying the success of such processes in inducing nucleation on a 56–m2 freeze dryer operating at a load of 195,960 vials.
This report describes the first known attempt at quantifying the success of such processes in inducing nucleation on a 56–m2 freeze dryer operating at a load of 195,960 vials.
Understanding of endotoxin assays and a range of detection technologies are essential for effective testing.
* Early investment and product characterization is key for biologics * What stages are best for product characterization? * Outsourced product characterization services
While the measurement of the toxicity of leachables is not always a required parameter, the information collected during these studies could inform future bioprocessing runs.
CDMOs can claim credit for the robust growth of emerging bio/pharma financings.
Delays in revisions to guidelines by the European Union are impeding the pharmaceutical industry.
The agency will be reorganizing field force and compliance functions.
The Trump administration unveiled a new drug price control policy, drawing opposition from pharma manufacturers and pharmacy benefit managers.
In this article, the authors explored the elimination of a water rinse and blow down following the caustic wash step, examining potential safety considerations, the effect on the quality of the cleaning process, and the potential benefit of implementing this change.
The authors describe the development and validation of a highly sensitive point-of-use pressure decay test.
The authors describe the development and validation of a highly sensitive point-of-use pressure decay test.
In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, discuss how to address an FDA warning letter citation for a failure to establish a quality control unit.
An orthogonal approach to lipid nanoparticle analysis is recommended to optimize drug development success.
Managing partnerships for the greater good.
This study aims at understanding the differences between porcine and bovine trypsin from both pancreatic and recombinant origins.
This study aims at understanding the differences between porcine and bovine trypsin from both pancreatic and recombinant origins.
This study aims at understanding the differences between porcine and bovine trypsin from both pancreatic and recombinant origins.
Making chemically defined media work.
Manufacturing for originator molecules is restricted by regulations, but drug makers can exploit newer technologies for the manufacture of biosimilars.
The authors describe an industrialized process for the manufacture of iPSC-derived human cardiomyocytes.
Get a better understanding of dissolved oxygen (DO) measurement in Hamilton's comprehensive O2 Measurement Guide. This 72-page booklet is intended for anyone with an interest in DO sensor technology or anyone who needs to implement DO sensors in controlled environments such as laboratories and industrial plants.